About Glycologix
Glycologix is a company based in Beverly (United States) founded in 2016 by Thomas H Jozefiak.. Glycologix has raised $4.05 million across 5 funding rounds from investors including HHS. The company has 7 employees as of December 31, 2022. Glycologix offers products and services including GLX-100 and Biopolymer Platform. Glycologix operates in a competitive market with competitors including Amphora Medical, EMKinetics, Cogentix Medical, EBT Medical and Valencia Technologies, among others.
- Headquarter Beverly, United States
- Employees 7 as on 31 Dec, 2022
- Founders Thomas H Jozefiak
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glycologix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.05 M (USD)
in 5 rounds
-
Latest Funding Round
- Investors
-
Employee Count
7
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glycologix
Glycologix offers a comprehensive portfolio of products and services, including GLX-100 and Biopolymer Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets interstitial cystitis for soft tissue protection and repair.
Provides technology for multiple unmet medical needs in tissue repair.
Unlock access to complete
Unlock access to complete
Funding Insights of Glycologix
Glycologix has successfully raised a total of $4.05M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Jun 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Seed - Glycologix | Valuation |
investors |
|
| Dec, 2025 | Amount | Debt – Conventional - Glycologix | Valuation |
investors |
|
| Apr, 2024 | Amount | Seed - Glycologix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glycologix
Glycologix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glycologix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glycologix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glycologix Comparisons
Competitors of Glycologix
Glycologix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amphora Medical, EMKinetics, Cogentix Medical, EBT Medical and Valencia Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiofrequency ablation device for overactive bladder treatment
|
|
| domain | founded_year | HQ Location |
Transdermal stimulation therapy is provided for urinary incontinence treatment.
|
|
| domain | founded_year | HQ Location |
Minimally invasive treatment of voiding dysfunctions and endoscopy solution
|
|
| domain | founded_year | HQ Location |
Non-invasive neurostimulation devices for overactive bladder are developed.
|
|
| domain | founded_year | HQ Location |
A coin-sized neuromodulation device for hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Neurostimulation devices for overactive bladder treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glycologix
Frequently Asked Questions about Glycologix
When was Glycologix founded?
Glycologix was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Glycologix located?
Glycologix is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.
Who is the current CEO of Glycologix?
Dan Deardorf is the current CEO of Glycologix.
Is Glycologix a funded company?
Glycologix is a funded company, having raised a total of $4.05M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jun 01, 2018.
How many employees does Glycologix have?
As of Dec 31, 2022, the latest employee count at Glycologix is 7.
What does Glycologix do?
Glycologix was founded in 2016 and is based in Beverly, United States. Operations center on the development of a non-systemic, highly cross-linked chondroitin sulfate-based biopolymer platform within the biotechnology sector. This platform addresses soft tissue protection and repair for conditions such as interstitial cystitis, dry eye, surgical adhesion prevention, osteoarthritis, disk disease, and wound repair.
Who are the top competitors of Glycologix?
Glycologix's top competitors include Valencia Technologies, Amphora Medical and EMKinetics.
What products or services does Glycologix offer?
Glycologix offers GLX-100 and Biopolymer Platform.
Who are Glycologix's investors?
Glycologix has 1 investor. Key investors include HHS.